SNYRegulatory•globenewswire•
Press Release: Sanofi’s rilzabrutinib earns orphan designation in the EU for IgG4-related disease
Sentiment:Positive (70)
Summary
Sanofi’s rilzabrutinib earns orphan designation in the EU for IgG4-related disease
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 14, 2025 by globenewswire